| Julie Thibeaux, | |
|
4515 Eddie Williams Ave, Alexandria, LA 71302-3628 | |
| (318) 443-4572 | |
| Not Available |
| Full Name | Julie Thibeaux |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4515 Eddie Williams Ave, Alexandria, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265147979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7221 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Thibeaux, 4515 Eddie Williams Ave, Alexandria, LA 71302-3628 Ph: () - | Julie Thibeaux, 4515 Eddie Williams Ave, Alexandria, LA 71302-3628 Ph: (318) 443-4572 |
News Archive
MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics.
For more than 100 years, scientists have tried to figure out the cell size problem: How does a cell know when it is big enough to divide, In research conducted in budding yeast ( Saccharomyces cerevisiae ), scientists at Rockefeller University have now identified the cellular event that marks the moment when a cell knows it is big enough to commit to cell division and spawn genetic replicas of itself.
A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.
High-intensity group workout classes are increasingly popular at fitness centers. While research has shown that these workouts can have cardiovascular and other benefits, few studies have been conducted on whether they lead to more injuries.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy.
› Verified 4 days ago
Elizabeth Landry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2006 Gus Kaplan Dr, Alexandria, LA 71301 Phone: 318-487-5020 | |
Mr. Brian D Warner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3912 Parliament Dr, Alexandria, LA 71303 Phone: 318-449-9221 Fax: 318-445-6697 | |
Mrs. Teresa O'dom Besson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Cinderella Ct, Alexandria, LA 71303 Phone: 318-481-0835 | |
Mrs. Elizabeth Y Erickson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-443-4572 | |
Crystal Hundley, CFY/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2006 Gus Kaplan Dr, Alexandria, LA 71301 Phone: 318-487-5395 Fax: 318-487-5463 | |
Melissa Mctire, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-442-5731 | |
Kristen Nicole Franklin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Eddie Williams Ave, Alexandria, LA 71302 Phone: 318-442-5731 |